Navigation Links
Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography
Date:7/12/2014

Albany, New York (PRWEB) July 12, 2014

This report covers the market analysis for various reagents used in the life science industry. Continuous innovation in biotechnology is driving the life science reagents market towards remarkable growth. The stakeholders for this study include manufacturers and providers of life science reagents.

Brows full Life Science Reagents Market Report: http://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html.

The global life science reagents market is categorized on the basis of various products that are commercially available and end users of life science reagents. The different product categories covered in this report include polymerase chain reaction (PCR) reagent kits, cell and tissue culture reagents, flow cytometry reagents, chromatography reagents, in-vitro diagnostic (IVD) reagents and others (gene expression reagents, mass spectroscopy reagents and transfection reagents). The end users for this market comprise commercial and contract manufacturers, research and academic institutes, hospital and clinical laboratories, and forensic laboratories. A detailed market analysis and revenue forecast for these segments has been provided in this study, in terms of USD million for the period 2011 to 2019. The report also provides the compounded annual growth rate (CAGR %) for each product type and end user segment for the forecast period 2013 to 2019, while the market size estimations have been made considering 2012 as the base year.

Get report sample copy here:

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Nanomedicine Market is Expected to Reach USD 177.60 Billion Globally in 2019: Transparency Market Research
2. Pharmacovigilance Benefit-Risk Assessments: Requirements, Transparency, and Implications, a New and Upcoming Drug Safety Webinar Hosted by Xtalks
3. Prefilled Syringes Market Expected to Reach USD 4.98 Billion Globally in 2019: Transparency Market Research
4. Hernia Repair Devices Market is Expected to Reach USD5.9 Billion Globally in 2019: Transparency Market Research
5. Arthroscopy Devices Market is Expected to Reach USD 5.1 Billion Globally in 2019: Transparency Market Research
6. SNP Genotyping and Analysis Market is Expected to Reach to USD 9.5 Billion Globally by 2019: Transparency Market Research
7. Anesthesia and Respiratory Devices Market is Expected to Reach USD 21.6 Billion Globally in 2019: Transparency Market Research
8. Blood Pressure Monitoring Testing Market is Expected to Reach USD 3.7 Billion Globally in 2019: Transparency Market Research
9. Global Salicylic Acid Market is Expected to Reach USD 521.2 million in 2019: Transparency Market Research
10. Companion Diagnostics Market is Expected to Reach USD 5.6 Billion Globally in 2019: Transparency Market Research
11. Global Medical Polymers Demand is Expected to Reach 6,411.7 kilo tons in 2018: Transparency Market Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 03, 2015 Experts and industry ... for one event: the Alltech REBELation exploring innovation, inspiration ... 17-20. Now in its 31st year, Alltech’s annual international ... countries, and the opportunity to join the REBELation at ... at 11:59 p.m. EST, at which point the standard ...
(Date:3/3/2015)... , March 3, 2015 /CNW/- SQI Diagnostics Inc. (TSX:V: ... proprietary technologies and products for advanced microarray diagnostics, ... CA, CFE  to its Management team. In his ... in its transition from a development stage to ... to advance the Company,s capital market strategy and ...
(Date:3/3/2015)... March 3, 2015  Regenicin, Inc. (OTC Bulletin Board: ... the development of and commercialization of regenerative cell therapies ... announced today that it has received the final payment ... Holdings, Inc. (OTC Bulletin Board: AMBS ). ... made the final payments due to Regenicin in the ...
(Date:3/3/2015)... Md. , March 3, 2015  RegeneRx Biopharmaceuticals, ... editorial in the scientific journal, Expert Opinion on ... his colleague, Dr. Zhenggang Zhang , at the ... reported that Thymosin beta 4 (TB4) has the ... remodeling 24 hours or more post-injury, leading to neurological ...
Breaking Biology Technology:World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3
... Allos,Therapeutics, Inc. (Nasdaq: ALTH ), a biopharmaceutical ... molecule therapeutics for,the treatment of cancer, today announced ... a corporate overview at the 2007 UBS Global ... presentation will take place at 3:30 p.m. (Eastern) ...
... Feature Public and Private Life Science Companies from ... ... for the,Southern California life science community, is proud to announce that ... Diego,Marriott Del Mar from Oct. 31-Nov. 2, 2007. Featuring almost ...
... Tissue Ligating ... ... surgical device company, has been named a 2007 Innovator of the,Year ... for its newest Tissue Ligating Shears, the TLS3,which uses the Company,s ...
Cached Biology Technology:Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference 2BIOCOM Announces Second Annual Investor Conference 2Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year 2
(Date:3/3/2015)... FOREST, Calif. , March 3, 2015 ... the leading provider of advanced cryogenic logistics ... markets including immunotherapies, stem cells, cell lines, ... and reproductive medicine, today announced the expansion ... Cancer Research Centers, ("Fred Hutch") Clinical ...
(Date:3/2/2015)... , March 2, 2015  Businesses have ... Data protection company Tharon Rankins Enterprises has announced ... provides an ultra-safe way for businesses to protect ... financial transactions. Beconux is a ... Rankins Enterprises. Functioning similarly to an ATM machine, ...
(Date:2/25/2015)... LITTLE ROCK, Ark. , Feb. 25, 2015 ... of software and billing in the Health and ... software as well as to MYiCLUBonline.  The latest ... MYiCLUBonline and the inclusion of cardless check-in via ... demonstrated for the first time through interactive displays ...
Breaking Biology News(10 mins):Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3Personal Data Protection Company Launches New Product 2ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3
... PASADENA, Calif.A California Institute of Technology (Caltech)-led ... first proof that a targeted nanoparticleused as an ... bloodstreamcan traffic into tumors, deliver double-stranded small interfering ... gene using a mechanism known as RNA interference ...
... A potential new energy source so controversial that people once ... by the mainstream scientific community. That,s the conclusion of the ... topic "cold fusion" being held here for the ... National Meeting of the American Chemical Society (ACS). "Years ...
... , , Michael M. Graham, Ph.D., M.D., president, ... chair, SNM Medical Isotope Task Force, Jeffrey P. Norenberg, ... member, SNM Medical Isotope Task Force, WHEN:,Immediately ... over a two-week period when cancer, heart and brain ...
Cached Biology News:Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles 2Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles 3Caltech-led team provides proof in humans of RNA interference using targeted nanoparticles 4'Cold fusion' moves closer to mainstream acceptance 2'Cold fusion' moves closer to mainstream acceptance 3'Cold fusion' moves closer to mainstream acceptance 4
... Ambions MAXIscript In Vitro Transcription Kits ... 1 x 10 9 cpm/g. High ... in ribonuclease protection assays, in situ hybridization, ... be used for the synthesis of modest ...
Mouse H60 Allophycocyanin MAb (Clone 205326) ENTREZ GeneID: 15101...
... 250 ul (125 precipitations). ... easy pellet location.Efficient precipitation ... inert, compatible with most ... protocol. Category: DNA/RNA Synthesis ...
... for monitoring Aldolase tests. 2 levels ... targeted manufacturing values at 4 ± ... IU/L. 30-day shelf life once ... Level 1: 3 x 3 ml; ...
Biology Products: